7498 Results (Page 30 of 300)
Pharmaceuticals Markets Research Reports
Thailand Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Thailand infectious disease therapeutics market will reach a value of $207.56 Mn from $143.84 Mn in 2022, growing at a CAGR of 4.7% during 2022-2030. Infectious Disease Therapeutics in Thailand is dominated by a few domestic pharmaceutical companies such as Siam Bioscience, BioNet-Asia and GPO. The Infectious Disease Therapeutics market in Thailand is segmented into different therapeutic areas and different diseases type. The major factors affecting the Thailand infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Thailand.
France Central Nervous System (CNS) Therapeutics Market Analysis
The France Central Nervous System (CNS) Therapeutics Market was valued at $5.775 Bn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $8.796 Bn by 2030. The key drivers of this industry include the surge in the prevalence of CNS disorders, increasing public health programs, and increased R&D activities. The industry is primarily dominated by players such as Pfizer, Janssen, Camber, Allergan, Lundbeck, Teva, Cipla, and Merck among others.
China Central Nervous System (CNS) Therapeutics Market Analysis
The China Central Nervous System (CNS) Therapeutics Market was valued at US $16.881 Bn in 2022 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to US $31.051 Bn by 2030. The key drivers of this industry include the increasing prevalence of CNS disorders, growing consumer demand, and supportive government policies. The industry is primarily dominated by players such as AbbVie, Pfizer, Shanghai Fosun, Green Valley, Lundbeck, and Hualan among others.
Canada Central Nervous System (CNS) Therapeutics Market Analysis
The Canada Central Nervous System (CNS)Therapeutics Market was valued at US $16.8 Bn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to US $27.596 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of CNS diseases, supportive government initiatives, and technological factors. The industry is primarily dominated by players such as Pfizer, Novartis, Teva Pharmaceutical, Otsuka, AbbVie, Roche, and Eli Lilly among others.
Brazil Central Nervous System (CNS) Therapeutics Market Analysis
The Brazil Central Nervous System (CNS)Therapeutics Market was valued at US $5.250 Bn in 2022 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to US $9.294 Bn by 2030. The key drivers of this industry include the increasing prevalence of CNS diseases, government initiatives, and new treatment options. The industry is primarily dominated by players such as Pfizer, Novartis, Biogen, AstraZeneca, Eli Lilly, Eurofarma, Merck, and Abbott among others.
UK Central Nervous System (CNS) Therapeutics Market Analysis
The UK Central Nervous System (CNS)Therapeutics Market was valued at $5.460 Bn in 2022 and is predicted to grow at a CAGR of 4.4% from 2023 to 2030, to $7.705 Bn by 2030. The key drivers of this industry include the surge in the prevalence of CNS disorders, increased healthcare expenditure, and supportive government initiatives. The industry is primarily dominated by players such as AbbVie, Pfizer, Eli Lilly, Teva, Biogen, and Novartis among others.
France Neurology Drugs Market Analysis
This report presents a strategic analysis of the France Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the France Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
Australia Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Australia Oncology Therapeutics Market will reach a value of $4.6 Bn from $2.2 Bn in 2022, growing at a CAGR of 9.9% during 2022-2030. The Oncology Therapeutics Market in Australia is dominated by a few domestic pharmaceutical companies such as CSL Behring, Mesoblast, and Sirtex Medical. The Oncology Therapeutics Market in Australia is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Australia Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Kenya ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Kenya's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to grow from $21 Mn in 2022 to $40 Mn in 2030 with a CAGR of 8.6% for the year 2022-2030. Improving health infrastructure and novel therapeutic options for the treatment of ADHD in Kenya are the major factors responsible for the growth of the market. The Kenya ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the major players in the market include Dinlas Pharma, Afinus Pharma, and Eli Lily.
Thailand Rheumatology Drugs Market Analysis
This report presents a strategic analysis of the Thailand Rheumatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Rheumatology Drugs Market, offering unmatched value, accuracy and expert insights.
Thailand ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Thailand ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy, and expert insights.
Vietnam Breast Cancer Therapeutics Market Analysis
The sharp increase in breast cancer cases and introduction of advanced therapeutics for the treatment of breast cancer has contributed significantly to the growth of Vietnam breast cancer therapeutics market from $91 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the period 2022-2030. The market is segmented by therapy, by cancer type, and by distribution channel. ImexPharm Pharmaceutical Joint Stock Company, Merck, and Syndax are some of the leading companies in the Vietnam breast cancer therapeutics market.
Vietnam Neurology Drugs Market Analysis
This report presents a strategic analysis of the Vietnam Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
Vietnam Cardiovascular Diseases Therapeutics Market Analysis
Vietnam's cardiovascular disease therapeutics market is projected to grow from $813 Mn in 2022 to $1,445 Mn in 2030 with a CAGR of 7.45% for the year 2022-2030. The rising incidence of cardiovascular diseases in Vietnam and increases governmental efforts in improving Vietnam's health infrastructure have resulted in the expansion of the market. The Vietnam cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Ha, Tay Pharmaceutical, OPC Pharmaceutical, and F. Hoffmann-La Roche are the major players in the Vietnam cardiovascular disease therapeutics market.
Africa Anti Aging Therapeutics Market Analysis
This report presents a strategic analysis of the Africa Anti Aging Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Africa Anti Aging Therapeutics Market, offering unmatched value, accuracy and expert insights.
Philippines Dialysis Market Analysis
This report presents a strategic analysis of the Philippines Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Philippines Dialysis Market, offering unmatched value, accuracy and expert insights.
Germany Oral Care Market Analysis
Germany's oral care market was valued at $1.29 Bn in 2022 and is estimated to expand at a CAGR of 4.4% from 2022 to 2030 and will reach $1.82 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, Increasing prevalence of dental diseases. The market is segmented by type, drug, and distribution channel. Some key players in this market are Elmex, Meridol, Dr. Best, Dontodent, blend-a-dent Biorepair, Odol-med3, Listerine, and Kukident.
Algeria Lung Cancer Drugs Market Analysis
This report presents a strategic analysis of the Algeria Lung Cancer Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Algeria Lung Cancer Drugs Market, offering unmatched value, accuracy and expert insights.
Argentina Rheumatology Drugs Market Analysis
This report presents a strategic analysis of the Argentina Rheumatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Rheumatology Drugs Market, offering unmatched value, accuracy and expert insights.
Argentina Sleep Disorders Market Analysis
This report presents a strategic analysis of the Argentina Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
Argentina Pharmaceutical Market Analysis
This report presents a strategic analysis of the Argentina Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Argentina Diabetes Therapeutics Market Analysis
This report presents a strategic analysis of the Argentina Diabetes Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Diabetes Therapeutics Market, offering unmatched value, accuracy and expert insights.
Argentina Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Argentina Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Argentina Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.
India Vaccines Market Analysis
This report presents a strategic analysis of the Indian vaccine market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indian vaccine market, offering unmatched value, accuracy, and expert insights.
India Radiotherapy Market Analysis
By 2030, it is anticipated that the India Radiotherapy Market will reach a value of $250 Mn from $126 Mn in 2022, growing at a CAGR of 9% during 2022-30. The Radiotherapy Therapeutics Market in India is dominated by a few domestic players such as Bhabha Atomic Research Centre (BARC), HCG Group, and Elekta. The radiotherapy market in India is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for India Radiotherapy is increasing on account of the rise in cancer cases in the country.
